These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37152662)

  • 1. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
    Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
    MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
    Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
    J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
    Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
    Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
    J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
    French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
    BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
    Gray E; Donten A; Karssemeijer N; van Gils C; Evans DG; Astley S; Payne K
    Value Health; 2017 Sep; 20(8):1100-1109. PubMed ID: 28964442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.
    Vianna FSL; Giacomazzi J; Oliveira Netto CB; Nunes LN; Caleffi M; Ashton-Prolla P; Camey SA
    Genet Mol Biol; 2019; 42(1 suppl 1):232-237. PubMed ID: 31170278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of using weight estimated from mammographic images
    Nair KP; Harkness EF; Gadde S; Lim YY; Maxwell AJ; Moschidis E; Foden P; Cuzick J; Brentnall A; Evans DG; Howell A; Astley SM
    Proc SPIE Int Soc Opt Eng; 2017 Mar; 10134():. PubMed ID: 34925706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background risk of breast cancer influences the association between alcohol consumption and mammographic density.
    Trinh T; Christensen SE; Brand JS; Cuzick J; Czene K; Sjölander A; Bälter K; Hall P
    Br J Cancer; 2015 Jun; 113(1):159-65. PubMed ID: 26035701
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.